Tag: Alzheimer’s
What Psychiatrists Should Know about Genes and Alzheimer’s Disease
by Edmund Howe, MD, JD Dr. Howe is Professor, Department of Psychiatry, Director, Programs in Medical Ethics, and Senior Scientist, Center for the Study of Traumatic Stress, Uniformed Services University of the Health Sciences, Bethesda, Maryland. Psychiatry (Edgemont) 2010;7(10):45–51
Core Ethical Questions: What Do You Do When Your Obligations as a Psychiatrist Conflict with Ethics?
by Edmund Howe, MD, JD Dr. Howe is Professor, Department of Psychiatry, Director, Programs in Medical Ethics, and Senior Scientist, Center for the Study of Traumatic Stress, Uniformed Services University of the Health Sciences, Bethesda, Maryland. Psychiatry (Edgemont) 2010;7(5):19–26
Use of Intramuscular Ziprasidone for the Control of Acute Psychosis or Agitation in an Inpatient Geriatric Population: An Open-Label Study
by Alina R. Rais, MD; Kristi Williams, MD; Theodor Rais, MD; Tanvir Singh, MD; and Marijo Tamburrino, MD Dr. Alina Rais is Associate Professor, Director Psychogeriatric Program of the University of Toledo Medical Center (UTMC), Toledo, Ohio; Dr. Williams is Associate Professor, Director Psychiatry Residency Training Program UTMC, Toledo, Ohio; Dr. Theodor Rais is Associate […]
Treatment Initiatives for Patients with Alzheimer’s Disease
by Edmund Howe, MD, JD Dr. Howe is Professor, Department of Psychiatry, Director, Programs in Medical Ethics, and Senior Scientist, Center for the Study of Traumatic Stress, Uniformed Services University of the Health Sciences, Bethesda, Maryland. Psychiatry (Edgemont) 2009;6(11):40–47
Ethical Aspects of Evaluating a Patient’s Mental Capacity
by Edmund Howe, MD, JD Dr. Howe is Professor, Department of Psychiatry, Director, Programs in Medical Ethics, and Senior Scientist, Center for the Study of Traumatic Stress, Uniformed Services University of the Health Sciences, Bethesda, Maryland.
Frontotemporal Dementia Complicated by Comorbid Borderline Personality Disorder: A Case Report
by LCDR Stephen Salzbrenner, MD; Jaime Brown; Gavin Hart; ENS Jonathan Dettmer; LT Raquel Williams, MD; LT Monica Ormeno, DO, USN; LCDR Ethel O’Neal, MD; and LT Jennifer Shippy, MD Dr. Salzbrenner is an Attending Staff Psychiatrist at Naval Medical Center in Portsmouth, Virginia; Ms. Brown is a third-year medical student at Edward Via Virginia […]
Using Nonevidence-based Approaches to Treat Patients with Alzheimer’s Disease
by Edmund Howe, MD, JD Dr. Howe is Professor, Department of Psychiatry, Director, Programs in Medical Ethics, and Senior Scientist, Center for the Study of Traumatic Stress, Uniformed Services University of the Health Sciences, Bethesda, Maryland.
Relative Tolerability of Alzheimer’s Disease Treatments
by Gustavo Alva, MD, and Jeffrey L. Cummings, MD Dr. Alva is from ATP Clinical Research, Costa Mesa, California, and Dr. Cummings is from the University of California, Los Angeles, Alzheimer’s Disease Research Center, Los Angeles, California
Use of Atypical Antipsychotics in the Elderly
by Elisa Cascade; Amir H. Kalali, MD; and Jeffrey L. Cummings, MD Ms. Cascade is Vice President, Quintiles Inc./iGuard, Falls Church, Virginia; Dr. Kalali is Vice President, Global Therapeutic Group Leader CNS, Quintiles Inc., San Diego, California, and Professor of Psychiatry, University of California, San Diego; and Dr. Cummings is from the Departments of Neurology […]
